XERS FY 2019 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+10.4% YoY

Gross Profit

$1M41.1% margin

Operating Income

-$122M-4496.0% margin

Net Income

-$126M-4613.5% margin

EPS (Diluted)

$-3.49

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$81M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$109M

Total Liabilities

$95M

Stockholders' Equity

$14M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+10.4%
Gross Profit	$1M	$2M	-53.8%
Operating Income	-$122M	-$59M	-106.2%
Net Income	-$126M	-$60M	-109.0%